It is indicated that osteopontin, Aurora-A, and phosphorylated ERK1/2 were coexpressed in aggressive HNSCC specimens, suggesting that they are, in most cases, related events in the development of HNSCC. This evidence concerns the gene MAPK3 and head and neck squamous cell carcinoma.